Vatche Bartekian’s Post

May 20th is National Clinical Trials Day, commemorating the first randomized clinical trial in 1747. This milestone in medical history has evolved into a vital part of modern medicine, driving advancements and finding cures for diseases like sarcoidosis. Clinical trials test new treatments and diagnostics, with patient participation being crucial. For rare diseases like sarcoidosis, finding eligible participants is challenging due to strict criteria and a small patient population. The Foundation for Sarcoidosis Research works to inform patients about trial opportunities through our website, social media, Patient Registry, and Clinical Trial Interest Indicator. Interested in joining a clinical trial? Talk to your sarcoidosis specialist or contact FSR for more information. Together, we can advance research and find better treatments for sarcoidosis. Learn more about current recruiting trials here: https://loom.ly/rzqlBcU Happy National Clinical Trials Day! 🎉 #ClinicalTrialsDay #Sarcoidosis #MedicalResearch #FSR

Every November, we all unite to raise awareness of lung cancer and support those affected. As this 𝗟𝘂𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵 comes to an end, let's not forget that we are stronger together—united! Through our collective efforts, we can provide better resources, stay abreast of the latest advancements in treatments options, ensure continuous education for both patients and healthcare professionals, and empower patients to actively participate in their treatment decisions. To support this mission, we have introduced new educational resources as part of our NSCLC education program, developed in collaboration with patients. These tools are designed to provide key information to ensure that patients have the essential knowledge needed to engage actively in shared decision making: 🔎 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹𝘀: A guide to biomarker testing and treatment options, empowering patients to make informed decisions 🔎 𝗖𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝘁𝗶𝗼𝗻 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗼𝗻: Outlines the roles of the multidisciplinary team and encourages open dialogue during consultations 🔗 Access our free resources: https://lnkd.in/eE3A3M47 ---- This independent medical education program is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc. #LungCancerAwarenessMonth #NSCLC #patientempowerment #biomarkertesting #targetedtherapies #medicaleducation #healthcare #strongertogether #lungcancer #SDM #continuingmedicaleducation #CME #independentmedicaleducation #IME #SpringerIME

🌍 🔬Celebrating Clinical Trials Day! 🧬 🌍 Today, we honor the incredible contributions of clinical trials to medical science and public health. Clinical Trials Day commemorates the first-ever randomized clinical trial conducted by James Lind in 1747, which led to the cure for scurvy. Clinical trials are the backbone of medical research, providing the necessary data to ensure new treatments are safe and effective. Every breakthrough in medicine, from life-saving cancer therapies to revolutionary vaccines, is built on the foundation of rigorous clinical research. 🧐Why Clinical Trials Matter:🧐 🔬Innovation: Clinical trials drive innovation, turning scientific discoveries into real-world treatments. 🔬Safety and Efficacy: They ensure new treatments are safe and effective for patient use. 🔬Patient Empowerment: Participants contribute to scientific advancement and gain access to cutting-edge therapies. 🔬Public Health: Trials are essential for advancing public health, leading to better prevention, diagnosis, and treatment options. 🤔How You Can Get Involved:🤔 👥Participate:Consider enrolling in a clinical trial. Whether you’re healthy or managing a condition, your involvement is invaluable. Check with local hospitals, universities, or clinical trial databases. 🗣️Spread the Word: Share information about clinical trials with your network to raise awareness and encourage participation. 🫂Advocate for funding and policies that promote clinical research. Today I’m filled with immense pride as I reflect on my journey into the clinical research industry. As a woman of color in this field, I am proud to contribute to this vital work. Diversity in clinical research is crucial, not just among participants but also among those conducting the trials. Representation matters, and it’s important for the research community to reflect the diverse populations we serve. A huge thank you to all the researchers, healthcare professionals, and especially the volunteers who participate in clinical trials. Your dedication and bravery help pave the way for a healthier future. #ClinicalTrialsDay

"I have budget for patient education on this clinical trial. How fast can PRIMR deliver?" This is one of the most common questions we get from prospective new partners. People are usually pleasantly surprised by our answer: ✍ 1 week to completed script 🎥 2-3 weeks to completed video 🥇 Ongoing IRB support within 1 business day How do we do it? We're the only patient education vendor that is doctor led and backed by a clinically integrated network of specialists in your trial domain. Speed without accuracy comes back to bite - we don't let that happen. Why do partners in the life sciences choose to work with us? Here's what they say when I ask: Time Savings: ▫ Accelerated timeline: Clinical trials often face tight schedules, and quick production of patient education materials can help keep the trial on track. ▫ Reduced bottlenecks: Faster creation of these resources prevents delays in patient recruitment and enrollment processes. Quality and Compliance: ◽ Regulatory adherence: Rapid turnaround without compromising compliance with regulatory requirements is highly valuable. ▫ Up-to-date information: Quick production ensures that materials reflect the most current protocol and study details. Cost Efficiency: ▫ Budget optimization: Faster delivery can lead to cost savings by reducing idle time and potentially accelerating the overall trial timeline. ▫ Resource allocation: Quick turnaround allows the clinical trial manager to allocate resources more efficiently. Patient-Centric Approach ▫ Improved patient experience: Timely availability of education materials enhances patient understanding and engagement. ▫ Increased recruitment potential: Well-prepared, readily available materials can boost patient interest and enrollment rates. Competitive Advantage ▫ Agility in trial management: Fast turnaround demonstrates adaptability and efficiency in trial operations. ▫ Potential for earlier market entry: Streamlined processes, including quick production of patient materials, can contribute to faster trial completion. Work with PRIMR for patient education on your clinical trial: https://lnkd.in/eTXSqb3P #clinicaltrials #clinicalresearch #cancerresearch #oncology #cro #research #patienteducation #breastcancer #lungcancer #prostatecancer

The goal of all clinical trials is to be as inclusive as possible. However, it is necessary to develop specific inclusion and exclusion criteria. The reason for this is to ensure that the study is valid—so that the study can determine if an experimental medication can safely and effectively treat a disease, such as scleroderma. In most clinical trials, some patients receive an active medication, while other patients receive a matching placebo. The inclusion and exclusion criteria are used to ensure that these two groups of patients in the trial are similar. This way, any differences in disease outcomes observed during the trial are truly due to the experimental medication. By focusing on a specific group of patients, such as those with scleroderma-associated ILD in CONQUEST, researchers can: 🔹 Ensure Safety: Specific criteria help protect participants by minimizing risks and ensuring the experimental medication is tested on those most likely to benefit. 🔹 Increase Accuracy: A well-defined patient population helps researchers clearly understand the effects of the experimental medication, leading to more reliable and meaningful results. 🔹 Improve Outcomes: Focused trials can lead to quicker and more definitive conclusions, accelerating the development of effective treatments for specific conditions. While not everyone can join every trial, each study contributes to the larger body of knowledge that will ultimately benefit all scleroderma patients. Every piece of research builds upon previous findings, paving the way for new, more inclusive trials and better treatments. At the SRF, we are unwavering in our dedication to funding scleroderma research that drives progress. Every clinical trial, like CONQUEST, plays a vital role in this mission. Learn more about clinical trials and their importance in scleroderma research: https://bit.ly/3WyHBhh #sclerodermaresearch #scleroderma #sayscleroderma #srfcure

"Clinical trial trends until the end of 2023 can be divided into two groups — those related to changes in the conduct of clinical trials and those related to the changes in the products of a given nosology." Here, Svyatoslav M. guides us through trends in clinical research, identifying which ones he believes will continue in 2024 and beyond. #clinicaltrials #clinicalresearch

🔬✨The world of clinical trials is rapidly evolving, and staying ahead of the curve is more crucial than ever. S.S. Milovanov’s insightful article, “Will Today’s Clinical Trial Trends Become Tomorrow’s Routine?” sheds light on the monumental shifts we’re witnessing—from the digitalization of clinical trials to the increasing focus on patient-centric approaches and groundbreaking biologics and gene therapies. At Exigyn we’re not just watching these trends—we’re leading the change! Our cutting-edge clinical budgeting software, bioTrial, is designed specifically for the life sciences sector, empowering researchers and finance teams to navigate the complexities of clinical trials more efficiently than ever. Whether it’s managing decentralized trials or integrating real-world data, Exigyn is your partner in driving innovation and precision in clinical research. 🚀🧬 Stay informed, stay ahead, and let’s shape the future of medicine together with Exigyn! 🌐🔬 #ClinicalTrials #DigitalHealth #PatientCentric #Biologics #GeneTherapy #RealWorldData #DecentralizedTrials #ClinicalResearch #FutureOfMedicine #HealthTech #LifeSciences

White House to Host Clinical Trials Forum - On Wednesday, June 26, 2024, the White House Office of Science and Technology Policy (OSTP) will convene the White House Clinical Trials Forum. Biden-Harris Administration leaders will meet with patients, caregivers, physicians, researchers, and private sector leaders to identify and implement effective strategies to improve clinical trials by increasing access, lowering barriers to participation, and speeding discovery of effective therapies. This will enable us to deliver on Biden-Harris Administration goals to improve health outcomes for all Americans and the Biden Cancer Moonshot goal to end cancer as we know it.   The forum will highlight progress, discuss challenges, and identify new actions to improve clinical trial participation and access, and foster equity in biomedical research. WHEN: Wednesday, June 26, 2024, 10:00 AM – 11:00 AM ET WHERE: The event will be livestreamed at https://lnkd.in/eq9dKxFg FEATURED PARTICIPANTS: Arati Prabhakar, Assistant to the President for Science and Technology, Director of the White House Office of Science and Technology Policy Danielle Carnival, Deputy Assistant to the President for the Cancer Moonshot, Deputy Director for Health Outcomes, OSTP Monica Bertagnolli, Director, NIH Renee Wegrzyn, Director, ARPA-H Rob Califf, Commissioner, FDA Kim Rathmell, Director, NCI Micky Tripathi, National Coordinator for Health Information Technology Chaundra Bishop, Clinical Trial Participant, Stage IV Cholangiocarcinoma Advocate Farid Vij, Citizen Health CONTACT: For press inquiries related to this event, please email [email protected]. BACKGROUND: Testing medical interventions through clinical trials is an essential part of creating and delivering effective health care for everyone in America. OSTP is leading a whole-of-government approach to bolster clinical trial capacity in the United States. By making clinical trials more efficient, inclusive, and streamlined, we can better contain infectious disease outbreaks and accelerate the development of new ways to prevent, detect, and treat cancer and other diseases. OSTP will continue to work with federal partners and the larger clinical research community to communicate about next steps, including unveiling plans to facilitate pragmatic trials across multiple sites and diverse communities; launching pilots to demonstrate more efficient data capture; pursuing opportunities to engage with communities; and establishing trust to support clinical research and expand the reach of innovation to more communities. Best wishes, White House Office of Public Engagement

How to report clinical trial results effectively 💡   In 2023, over 22,000 clinical trials kicked off, highlighting how busy the year was for medical research. With oncology and central nervous system studies leading the pack, there's a lot of new information to share and report.    Pro tips to report your clinical trial results:   ✔️Clearly outline your trial's objective, design, and methodology; ✔️Be transparent and share all results, good or bad; ✔️Adhere to established reporting standards like CONSORT or STROBE; ✔️Use charts and graphs for clarity and visual assistance; ✔️Provide an easy-to-understand research overview; ✔️Discuss what your results mean for the field; ✔️Make it accessible by publishing in peer-reviewed and open-access journals; ✔️Reach the audience through media by crafting press releases that highlight the key findings.   By following these steps, you can report your clinical trial results in a way that's comprehensive, clear, and conducive to advancing healthcare and scientific understanding.

How do you engage with your community? If clinical research doesn’t come to mind, it should. From the scientific community to everyday people living with common and rare conditions, research makes a real difference. Clinical trial awareness starts with education. Learn more at Clinical Trials For All: https://lnkd.in/gTbHuDvt